Biodesix, Inc. reaffirmed revenue guidance for the year 2022. For the year, company expects to generate between $37.5 million and $39.5 million in total revenue in 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.6 USD | +1.27% | +20.30% | -13.04% |
21/05 | Biodesix, Inc. to Present New Data on the Nodify XL2 Test at ATS 2024 Annual Meeting | CI |
13/05 | TD Cowen Starts Biodesix With Buy Rating, $2.80 Price Target | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.04% | 232M | |
-21.01% | 8.05B | |
+68.16% | 4.32B | |
+6.69% | 2.74B | |
-2.98% | 2.6B | |
-50.95% | 1.97B | |
-18.54% | 1.68B | |
-21.29% | 1.45B | |
+16.69% | 1.2B | |
-44.86% | 1.12B |
- Stock Market
- Equities
- BDSX Stock
- News Biodesix, Inc.
- Biodesix, Inc. Reaffirms Revenue Guidance for the Year 2022